Our TRPV3 inhibitors represent a cutting-edge approach to patient care. TRPV3 is the master regulator of skin homeostasis.
Kamari’s TRPV3 inhibitors repair skin damage in rare skin diseases and severe chronic itch.

Kamari Pharma is developing innovative treatments for unmet needs and rare skin diseases.
Our team consists of experts who bring a wealth of experience and innovative ideas to the realm of skin disorders.